MK0457 in Patients With Leukemia (0457-003)

Clinical trial NCT00111683 · COMPLETED

Trial details

NCT number: NCT00111683
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia in Blast Crisis Lymphocytic Leukemia, B Cell, Acute Myelodysplastic Syndromes Myelogenous Leukemia, Chronic

Start date: 2005-06-01
Primary completion: 2008-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.